Nipro presents CURACASE™ - hypodermic needles in hard-plastic unit packaging
The launch1 of the CURACASE™ needles further strengthens our ability to manufacture and supply complete injection systems2 for the pharmaceutical industry.
Each CURACASE™ needle is individually packed in a compact hard-plastic packaging that takes up little space in a secondary packaging when by-packed. Its design supports compatibility with feeders and automated pick-and-place systems3. Furthermore, each unit pack is sealed with a color-coded label equipped with a barcode allowing in-line product identification by a vision system. All attributes of the unit pack contribute to a smooth packing process.
Nipro PharmaPackaging is a division of Nipro Corporation Japan, one of the leading manufacturers of globally renowned cannula-based injection devices. With this extensive in-house expertise, the results are needles with exceptionally sharp lancet points and homogeneously siliconized cannulas, supporting smooth administrations.
The needle hub complies to ISO 80369-7, allowing a proper connection to syringes.
CURACASE™ needles will be manufactured at a dedicated Nipro plant in Japan whose quality system complies to ISO 13485 and ISO 14001. The newly installed assembly lines, featuring sophisticated manufacturing and inspection technologies, fulfill the strict Japanese and international quality requirements.
Nipro PharmaPackaging offers a broad range of glass primary packaging, such as D2F™ pre-fillable syringes, D2F™ vials, cartridges and ampoules. In combination with our growing range of reconstitution devices, Nipro serves you as a single supplier for complete injection systems2.
